Canada markets closed

Royalty Pharma plc (RPRX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
28.09+0.12 (+0.43%)
At close: 04:00PM EDT
28.00 -0.09 (-0.32%)
After hours: 07:50PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 12.67B
Enterprise Value 17.27B
Trailing P/E 15.78
Forward P/E 8.26
PEG Ratio (5 yr expected) 1.17
Price/Sales (ttm)7.53
Price/Book (mrq)1.95
Enterprise Value/Revenue 8.91
Enterprise Value/EBITDA 47.04

Trading Information

Stock Price History

Beta (5Y Monthly) 0.47
52-Week Change 3-18.18%
S&P500 52-Week Change 326.27%
52 Week High 334.74
52 Week Low 325.92
50-Day Moving Average 329.10
200-Day Moving Average 328.65

Share Statistics

Avg Vol (3 month) 32.83M
Avg Vol (10 day) 33.3M
Shares Outstanding 5450.98M
Implied Shares Outstanding 6597.44M
Float 8388.11M
% Held by Insiders 113.40%
% Held by Institutions 171.89%
Shares Short (Apr 30, 2024) 413.75M
Short Ratio (Apr 30, 2024) 45.13
Short % of Float (Apr 30, 2024) 43.17%
Short % of Shares Outstanding (Apr 30, 2024) 43.05%
Shares Short (prior month Mar 28, 2024) 412.39M

Dividends & Splits

Forward Annual Dividend Rate 40.84
Forward Annual Dividend Yield 42.99%
Trailing Annual Dividend Rate 30.81
Trailing Annual Dividend Yield 32.90%
5 Year Average Dividend Yield 4N/A
Payout Ratio 445.51%
Dividend Date 3Jun 14, 2024
Ex-Dividend Date 4May 16, 2024
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin 35.69%
Operating Margin (ttm)-12.99%

Management Effectiveness

Return on Assets (ttm)3.54%
Return on Equity (ttm)12.06%

Income Statement

Revenue (ttm)2.24B
Revenue Per Share (ttm)4.99
Quarterly Revenue Growth (yoy)-17.00%
Gross Profit (ttm)N/A
EBITDA N/A
Net Income Avi to Common (ttm)798.86M
Diluted EPS (ttm)1.78
Quarterly Earnings Growth (yoy)-98.60%

Balance Sheet

Total Cash (mrq)872M
Total Cash Per Share (mrq)1.93
Total Debt (mrq)6.14B
Total Debt/Equity (mrq)62.24%
Current Ratio (mrq)12.52
Book Value Per Share (mrq)14.41

Cash Flow Statement

Operating Cash Flow (ttm)2.62B
Levered Free Cash Flow (ttm)-1.13B